Search research articles
Contact Us
Filters
Showing results (171-180 of 332) with videos related to
Page
of 34
Sort By:
Current Neuropharmacology
|
August 4, 2025
Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer’s Disease
Elliot J. Glotfelty, Tobias E. Karlsson, Luis B. Tovar-y-Romo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2002
A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells
TracyAnn Perry, Debomoy K Lahiri, Demao Chen, et al.
CNS & Neurological Disorders Drug Targets
|
October 28, 2014
Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression
Hanuma K Karnati, Manas Panigrahi, Noor A Shaik, et al.
ACS Medicinal Chemistry Letters
|
August 10, 2010
Preparation and Characterization of Tetrabenazine Enantiomers against Vesicular Monoamine Transporter 2
Qian-Sheng Yu, Weiming Luo, Jeffery Deschamps, et al.
Virusdisease
|
December 13, 2018
Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
Sayed Sartaj Sohrab, Mohd Suhail, Ashraf Ali, et al.
Bioorganic & Medicinal Chemistry
|
June 11, 2011
Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity
Weiming Luo, Qian-sheng Yu, Isidro Salcedo, et al.
Journal of Neuroinflammation
|
April 17, 2015
Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice
Renana Baratz, David Tweedie, Jia-Yi Wang, et al.
CNS & Neurological Disorders Drug Targets
|
October 18, 2011
Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study
Shazi Shakil, Rosina Khan, Shams Tabrez, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 1, 2008
Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis
Mohammad A Kamal, Xianqin Qu, Qian-Sheng Yu, et al.
CNS & Neurological Disorders Drug Targets
|
February 9, 2017
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
Mohammad A Kamal, Shazi Shakil, Muhammad S Nawaz, et al.
Page
of 34
Search research articles
Search
Showing results (171-180 of 332) with videos related to
Sort By:
Page
of 34
Current Neuropharmacology
|
August 4, 2025
Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer’s Disease
Elliot J. Glotfelty, Tobias E. Karlsson, Luis B. Tovar-y-Romo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2002
A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells
TracyAnn Perry, Debomoy K Lahiri, Demao Chen, et al.
CNS & Neurological Disorders Drug Targets
|
October 28, 2014
Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression
Hanuma K Karnati, Manas Panigrahi, Noor A Shaik, et al.
ACS Medicinal Chemistry Letters
|
August 10, 2010
Preparation and Characterization of Tetrabenazine Enantiomers against Vesicular Monoamine Transporter 2
Qian-Sheng Yu, Weiming Luo, Jeffery Deschamps, et al.
Virusdisease
|
December 13, 2018
Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
Sayed Sartaj Sohrab, Mohd Suhail, Ashraf Ali, et al.
Bioorganic & Medicinal Chemistry
|
June 11, 2011
Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity
Weiming Luo, Qian-sheng Yu, Isidro Salcedo, et al.
Journal of Neuroinflammation
|
April 17, 2015
Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice
Renana Baratz, David Tweedie, Jia-Yi Wang, et al.
CNS & Neurological Disorders Drug Targets
|
October 18, 2011
Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study
Shazi Shakil, Rosina Khan, Shams Tabrez, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 1, 2008
Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis
Mohammad A Kamal, Xianqin Qu, Qian-Sheng Yu, et al.
CNS & Neurological Disorders Drug Targets
|
February 9, 2017
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
Mohammad A Kamal, Shazi Shakil, Muhammad S Nawaz, et al.
Page
of 34